Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 800 results for "amgen rank"

Amgen Upgraded to Strong Buy, Perfect for Your Portfolio - Ana...

On Apr 11, Zacks Investment Research upgraded Amgen Inc. AMGN to a Zacks Rank #1 (Strong Buy). Why the Upgrade? Biotech company Amgen exited 2014 on a strong note with delivering positive earnings surprises in the last 4 quarters with an average ..., 1 month ago
Business Insider

The 25 best healthcare companies to work for in America

Twitter/@Amgen We partnered with employer-information website PayScale to find the . A number of healthcare companies topped the list, so we've featured them here. Pharmaceutical companies Amgen and Bristol-Myers Squibb took the top two spots, ...
 Business Insider3 days ago

Amgen (AMGN) Showing Resistance Near $165.04

Amgen Inc ( AMGN ) traded between $162.46 and $164.12 before closing at $163.56 Tuesday and presents some attractive trading opportunities today according to's patented algorithms. The computer program that picks trades ...
 TradingCharts.com3 days ago Amgen (AMGN) Trading Near $160.24 Support Level  TradingCharts.com4 days ago Amgen (AMGN) Trading Near $161.89 Support Level  Individual.com1 day ago Potential Amgen (AMGN) Trade Has 2.21% Downside Protection  TradingCharts.com1 week ago

Amgen (AMGN) Showing Bearish Technicals With Support At $157.19

( via COMTEX) --'s patented algorithms have identified an attractive covered-call trade on Amgen Inc ( AMGN ). Look at the Jul. '15 $165.00 covered call for a net debit in the $155.26 area. ...
 TradingCharts.com2 weeks ago Amgen (AMGN) Showing Bullish Technicals With Support At $163.31  Individual.com1 month ago

VeloNews: Tour of California storylines

0 Shares Print Comment Now one of the longest-running international stage races in U.S. history, the Amgen Tour of California celebrates its 10th edition when it kicks off on Sunday in Sacramento. Launched in 2005 and first held in February ...
 ESPN.com2 weeks ago Ride the Amgen Tour of California with ZWIFT and Jensie!  Triathlonbusiness.com3 weeks ago
Motley Fool

Amgen adding 100 researchers in Cambridge as biotechs scout for 1,000-plus

While Amgen ($AMGN) has been busily chopping thousands of staffers throughout its organization while reducing its R&D budget, one of its goals in the restructuring--which was repeated in its 10Q earlier this week--was to beef up its presence in two ...
 FierceBiotech3 weeks ago Could Celgene Corporation Muscle Its Way Past Amgen Inc.?  Motley Fool1 month ago

The Zacks Analyst Blog Highlights: Celladon, Amgen, Biogen and Alnylam Pharmaceuticals - Press Releases

For Immediate Release Chicago, IL April 29, 2015 announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.
 Zacks.com3 weeks ago

Zacks Industry Outlook Highlights: Orexigen, MannKind, Amgen, Medivation and Express Scripts - Press Releases

Today, Zacks Equity Research discusses the Pharma/Bio, including Orexigen ( OREX - Free Report ), MannKind ( MNKD - Free Report ), Amgen ( AMGN - Free Report ), Medivation ( MDVN - Free Report ) and Express Scripts ( ESRX - Free Report ). ...
 Zacks.com2 months ago Zacks Investment Ideas feature highlights: Biogen, Amgen, SPDR S&P Biotech ETF, BioShares Biotechnology …  Yahoo! Finance2 months ago

Amgen Gets FDA Nod for Chronic Heart Failure Drug Corlanor - Analyst Blog

Positive news flowed in for Amgen Inc . AMGN when the FDA approved its chronic heart failure drug, Corlanor (ivabradine). Corlanor has been approved to reduce the risk of hospitalization for worsening heart failure in patients suffering from ...
 Zacks.com1 month ago Recommendations on pre-hospital and early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emerge  European Heart Journal2 days ago

Amgen Announces Positive Results on Migraine Candidate - Analyst Blog

Amgen Inc . AMGN announced positive results from a phase II study on pipeline candidate, AMG 334. The study is evaluating the efficacy and safety of AMG 334 for the prevention of episodic migraine. Patients enrolled in the study were randomized to ...
 Zacks.com1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less